Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
72.22B | 68.39B | 65.62B | 53.51B | 51.25B | 58.30B | Gross Profit |
12.26B | 10.97B | 8.98B | 6.59B | 6.51B | 7.05B | EBIT |
5.05B | 3.75B | 2.15B | 536.00M | 359.00M | 599.00M | EBITDA |
7.29B | 6.45B | 4.20B | 2.54B | 2.58B | 2.97B | Net Income Common Stockholders |
2.83B | 3.22B | 1.02B | 510.00M | -433.00M | 2.04B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.15B | 5.29B | 4.42B | 2.39B | 5.66B | 3.67B | Total Assets |
54.09B | 53.86B | 51.55B | 50.28B | 46.85B | 47.88B | Total Debt |
13.04B | 13.01B | 14.37B | 16.61B | 14.28B | 14.29B | Net Debt |
5.89B | 7.72B | 9.94B | 14.21B | 8.62B | 10.62B | Total Liabilities |
31.13B | 31.30B | 33.10B | 33.02B | 30.57B | 31.08B | Stockholders Equity |
22.94B | 22.54B | 18.43B | 17.25B | 16.27B | 16.79B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.16B | 4.54B | -5.31B | 1.89B | -3.20B | Operating Cash Flow |
0.00 | 3.17B | 6.27B | -1.02B | 3.49B | -46.00M | Investing Cash Flow |
0.00 | -725.00M | -1.46B | -4.19B | -1.02B | -480.00M | Financing Cash Flow |
0.00 | -1.90B | -2.70B | 1.74B | -221.00M | 928.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥16.05B | 7.33 | 2.87% | -5.40% | ― | ||
72 Outperform | ¥17.27B | 7.04 | 5.71% | 8.72% | 16.58% | ||
72 Outperform | ¥13.85B | 8.90 | 3.86% | 9.25% | -19.42% | ||
70 Outperform | ¥14.98B | 5.44 | 4.01% | 6.16% | -14.38% | ||
62 Neutral | $6.91B | 11.20 | 2.93% | 3.90% | 2.68% | -25.01% | |
60 Neutral | ¥22.55B | 30.31 | 4.49% | 1.74% | -82.49% | ||
54 Neutral | ¥19.26B | ― | 3.01% | 0.66% | -340.28% |